Sign in

eyegenes.bsky.social

@eyegenes.bsky.social
10 followers 20 following 5 posts
PostsRepliesMedia
eyegenes.bsky.social @eyegenes.bsky.social · 14/07/2026
GoOD Meeting abstract submission deadline extended until 31 July! There is still time to submit an abstract!
Poster with details of the 2026 GoOD Meeting, showing a nighttime image of Montreal

text:
Welcome to the GoOD Meeting!
Montreal, Canada, 19-20 October 2026
An international multidisciplinary meeting bringing together clinicians and scientists interested in genetics of developmental eye anomalies
Keynote Speakers:
Michel Cayouette (Institut de Recherches Cliniques de Montréal, Canada), 
Elise Heon (Sick Kids Hospital Toronto, Canada) &
Brian Brooks (National Eye Institute, Bethesda, Maryland, USA)
Location: CHU Sainte Justine, Montreal, Canada, 
(immediately before ASHG meeting, Montreal)
Extended abstract deadline: 31st July 2026
www.goodsoc.org
100
Reposted by @eyegenes.bsky.social
medRxivpreprint @medrxivpreprint.bsky.social · 30/06/2026
The +57C>T substitution in microRNA-184 is associated with microphthalmia, retinal detachment, and altered ocular development www.medrxiv.org/content/10.64898/20…
001
Reposted by @eyegenes.bsky.social
franmartinezgr.bsky.social @franmartinezgr.bsky.social · 06/07/2026
Bi-allelic variants in CDK20 cause a severe ciliopathy with midline brain and facial anomalies #RareDisease #Genetics #morbidgene www.cell.com/ajhg/abstrac...
cell.com
Bi-allelic variants in CDK20 cause a severe ciliopathy with midline brain and facial anomalies
CDK20 is a ciliary kinase not previously linked to human disease. Lemire et al. report seven individuals with bi-allelic CDK20 variants, midline brain and facial anomalies, and impaired cilium formati...
001
Reposted by @eyegenes.bsky.social
European Society of Human Genetics @eshg.bsky.social · 12/06/2026
The #eshg2026 starts tomorrow morning. You can still register until June 16 for in-person participation. Enjoy all sessions live in Gothenburg, online from wherever you are or on-demand after the conference, whenever it suits you. 2026.eshg.org/registration/ #genetics #genomics
0115
Reposted by @eyegenes.bsky.social
European Journal of Human Genetics @ejhg-journal.bsky.social · 02/06/2026
📢 Structural variants disrupting PITX2 from its enhancers linked to Axenfeld-Rieger Syndrome highlight the importance of non-coding structural variants in genetic diagnoses. 🧬 🔗 Read more: www.nature.com/articles/s41...
nature.com
Non-coding structural variants disrupting conserved PITX2 enhancer loci in Axenfeld–Rieger syndrome - European Journal of Human Genetics
European Journal of Human Genetics - Non-coding structural variants disrupting conserved PITX2 enhancer loci in Axenfeld–Rieger syndrome
033
Reposted by @eyegenes.bsky.social
European Society of Human Genetics @eshg.bsky.social · 01/06/2026
🧬The first dataset pairing WGS with high-depth RNA-seq from key retinal tissues has been released. 👁️This resource reveals how common and rare genetic variation regulates retinal gene expression, offering new insights into retinal disorders. Full paper: www.nature.com/articles/s41...
052
Reposted by @eyegenes.bsky.social
Ophthopedia @ophthalmology.bsky.social · 24/05/2026
Ophthopedia Update: Posterior microphthalmia related to PRSS56 variants in a Saudi cohort: a longitudinal study of visual function: To report clinical, multimodal imaging, electrophysiologic, and genetic findings in a cohort of patients with posterior… #Ophthalmology #Eye #Ophthotwitter
dlvr.it
Posterior microphthalmia related to PRSS56 variants in a Saudi cohort: a longitudinal study of visual function
To report clinical, multimodal imaging, electrophysiologic, and genetic findings in a cohort of patients with posterior microphthalmia (PM), with emphasis on long-term visual function, a feature rarely addressed in current literature.
001
Reposted by @eyegenes.bsky.social
franmartinezgr.bsky.social @franmartinezgr.bsky.social · 10/12/2025
Intragenic loss-of-function variants in transcription factors MAZ, FOXP1 and SIN3B in colobomatous microphthalmia #RareDisease #Genetics #morbidgene jmg.bmj.com/content/earl...
jmg.bmj.com
Intragenic loss-of-function variants in transcription factors MAZ, FOXP1 and SIN3B in colobomatous microphthalmia
Despite the identification of many genes involved in developmental eye phenotypes, a large percentage of families lack genetic diagnoses, suggesting novel mechanisms remain to be discovered. Large del...
011
Reposted by @eyegenes.bsky.social
franmartinezgr.bsky.social @franmartinezgr.bsky.social · 14/05/2026
A next-generation episignature for Kabuki syndrome enables fine mapping of the impact of KMT2D variants to inform precision medicine #RareDisease #Genetics www.cell.com/ajhg/abstrac...
cell.com
A next-generation episignature for Kabuki syndrome enables fine mapping of the impact of KMT2D variants to inform precision medicine
A next-generation KMT2D episignature, defined using the largest Kabuki syndrome type 1 cohort to date, can be used to map pathogenic variants using array or long-read platforms, to improve missense va...
001
Reposted by @eyegenes.bsky.social
Shifeng Xue @shifengxue.bsky.social · 11/04/2026
Excited to share our new manuscript! Why do people with Bosma #arhinia microphthalmia syndrome (BAMS) not form noses? We show that #iPSCs from these patients are less able to form cranial placode cells, one of the cell types that make up the nose. www.cell.com/stem-cell-re...
cell.com
Cranial placode differentiation defect in individuals born without a nose
Xue and colleagues show that iPSCs from Bosma syndrome (BAMS) individuals have a reduced capacity of differentiation into cranial placode cells and the subsequent lens and olfactory lineages. These ce...
121
Reposted by @eyegenes.bsky.social
Elfride De Baere @elfridedebaere.bsky.social · 14/04/2026
🧬 Abstract submissions are now open for #ASHG26 Share your discoveries, connect with the global human genetics and genomics community, and help drive real‑world impact. Submissions are due May 18. Submit now: ashgmeeting.ashg.org/programs/abs...
021
Reposted by @eyegenes.bsky.social
Fabiola Ceroni @ceronifabiola.bsky.social · 10/04/2026
KDM2B or Not to Be 👀 Are structural eye anomalies part of the KDM2B clinical spectrum? We report 2 new cases with variants in the CxxC domain and congenital eye anomalies, supporting inclusion of KDM2B in diagnostic panels for #anophthalmia #microphthalmia #coloboma www.nature.com/articles/s41...
021
Reposted by @eyegenes.bsky.social
Cerys Manning Lab @manning-lab.bsky.social · 09/04/2026
How do YAP1 variants cause ocular coloboma? 👁️ Coloboma is a congenital eye disorder caused by a tissue fusion defect, affecting ~1 in 5000 births and leading to visual impairment.
Microscopy image of the optic fissure in human embryos
152
Reposted by @eyegenes.bsky.social
Michel Cayouette @michelcayouette.bsky.social · 09/04/2026
Excited to participate in this meeting. Promises to be a very interesting event, consider joining us!!
011
eyegenes.bsky.social @eyegenes.bsky.social · 09/04/2026
The 7th GoOD (Genetics of Ocular Development) Meeting will take place in Montreal, Canada on 19 and 20 October 2026, ahead of the ASHG annual meeting. More information on www.goodsoc.org
Flyer announcing the 7th Genetics of Ocular Development (GoOD) Meeting, to be held in Montreal, Canada on 19 and 20 October 2026
233